Turn Therapeutics Inc.
TTRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002023016
No open-market purchases or sales by Turn Therapeutics Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $8.48M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Turn Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Turn Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Golden Arthur F | Director | 360,602 | Jun 8, 2026 | 6 |
| Gengos Andrew | Director | 10,000 | Jun 8, 2026 | 2 |
| Kester Kent Edward | Director | 10,000 | Jun 8, 2026 | 2 |
| Dewhurst Martin William | Director | 21,882 | Jun 8, 2026 | 2 |
| BEB Holdings, LLC | 10% Owner | 300,000Indirect | Jun 1, 2026 | 3 |
| Burnam Bradley Evan | Chief Executive Officer | 300,000Indirect | Jun 1, 2026 | 3 |
| Chaudhary Zuraiz | See Remarks | 12,500 | Apr 3, 2026 | 6 |
| Chesed Abraham | Other: Board Observer | 1,447,268Indirect | Oct 29, 2025 | 1 |
| Ghodadra Neilesh Shailesh | Chief Medical Officer | 10,000 | Oct 10, 2025 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 (view filing) | Dec 12 | Same day | Chaudhary ZuraizSee Remarks | PPurchase | +2.50K | $3.50 | +$8.75K | +25.0%12.5K after | |
| Nov 25, 2025 (view filing) | Nov 24 | 1 day | Golden Arthur FDirector | PPurchase | +9.87K | $3.44 | +$33.9K | +19.5%60.6K after | |
| Nov 24, 2025 (view filing) | Nov 21 | 3 days | Golden Arthur FDirector | PPurchase | +20.5K | $2.87 | +$58.9K | +68.0%50.7K after | |
| Nov 21, 2025 (view filing) | Nov 20-21 | 1 day | Chaudhary ZuraizSee Remarks | PPurchase | +2.45K | $2.89 | +$7.07K | +32.5%10.0K after | 2 lots |
| Nov 17, 2025 (view filing) | Nov 17 | Same day | Chaudhary ZuraizSee Remarks | PPurchase | +2.50K | $3.62 | +$9.05K | +49.5%7.55K after | |
| Oct 29, 2025 (view filing) | Oct 23 | 6 daysLate | Chesed AbrahamOther: Board Observer | PPurchase | +14.3K | $4.60 | +$65.7K | +1.0%1.45M after | |
| Oct 23, 2025 (view filing) | Oct 23 | Same day | Chaudhary ZuraizSee Remarks | PPurchase | +5.05K | $4.95 | +$25.0K | New position5.05K after | |
| Oct 23, 2025 (view filing) | Oct 23 | Same day | Golden Arthur FDirector | PPurchase | +20.2K | $4.95 | +$100.0K | +202.0%30.2K after |